TASE

Pluristem appoints Yaky Yanay as CEO alongside Zami Aberman as Executive Chairman

– ISRAEL, Haifa –  Pluristem Therapeutics Inc. (Nasdaq: PSTI | TASE: PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced the completion of the transition period of its Co-CEO structure and the appointment of Yaky Yanay as sole Chief Executive Officer and President of Pluristem and the appointment of Zami Aberman as Executive Chairman of the Board.…

Brainsway welcomes Pr Abraham Zangen to its Board of Directors

– ISRAEL, Jerusalem –  Brainsway Ltd. (NASDAQ:BWAY / TASE:BWAY), a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation system (Deep TMS) technology for the treatment of major depressive disorder and obsessive-compulsive disorder, today announced that Professor Abraham Zangen, Ph.D.,…

Protalix BioTherapeutics appoints Dror Bashan to its Board of Directors as CEO

– ISRAEL, Karmiel –  Protalix BioTherapeutics, Inc. (NYSE: PLX, TASE: PLX), today announced that Dror Bashan has been appointed to serve as the Company’s new President and Chief Executive Officer, and a director, effective June 30, 2019, replacing Moshe Manor, who is stepping down from those roles for personal reasons.…